Insufficient scRNA-seq data for expression of SLC5A7 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 95% | 288.52 | 20 / 21 | 23% | 0.97 | 115 / 504 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.75 | 1 / 1 |
adrenal gland | 70% | 99.42 | 181 / 258 | 28% | 2.69 | 65 / 230 |
intestine | 89% | 415.08 | 864 / 966 | 1% | 0.03 | 7 / 527 |
prostate | 78% | 97.27 | 191 / 245 | 1% | 0.01 | 4 / 502 |
kidney | 76% | 48.26 | 68 / 89 | 1% | 0.14 | 9 / 901 |
esophagus | 68% | 221.34 | 985 / 1445 | 2% | 0.16 | 4 / 183 |
thymus | 63% | 42.32 | 409 / 653 | 7% | 0.38 | 43 / 605 |
stomach | 58% | 118.78 | 207 / 359 | 5% | 0.11 | 14 / 286 |
uterus | 51% | 53.93 | 86 / 170 | 4% | 0.17 | 18 / 459 |
lung | 38% | 23.34 | 221 / 578 | 12% | 1.03 | 135 / 1155 |
heart | 37% | 29.21 | 317 / 861 | 0% | 0 | 0 / 0 |
brain | 34% | 126.58 | 886 / 2642 | 0% | 0.01 | 2 / 705 |
breast | 28% | 25.09 | 128 / 459 | 5% | 0.42 | 53 / 1118 |
ovary | 29% | 22.79 | 53 / 180 | 0% | 0.05 | 2 / 430 |
adipose | 23% | 12.59 | 276 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 18% | 9.22 | 244 / 1335 | 0% | 0 | 0 / 0 |
pancreas | 7% | 2.88 | 23 / 328 | 11% | 0.19 | 19 / 178 |
tonsil | 0% | 0 | 0 / 0 | 9% | 0.42 | 4 / 45 |
liver | 4% | 1.21 | 9 / 226 | 0% | 0.01 | 1 / 406 |
skin | 3% | 1.04 | 52 / 1809 | 0% | 0.00 | 1 / 472 |
spleen | 1% | 0.59 | 2 / 241 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.04 | 1 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001701 | Biological process | in utero embryonic development |
GO_0055085 | Biological process | transmembrane transport |
GO_0008292 | Biological process | acetylcholine biosynthetic process |
GO_0007274 | Biological process | neuromuscular synaptic transmission |
GO_0006814 | Biological process | sodium ion transport |
GO_0006836 | Biological process | neurotransmitter transport |
GO_0015871 | Biological process | choline transport |
GO_0007271 | Biological process | synaptic transmission, cholinergic |
GO_0005886 | Cellular component | plasma membrane |
GO_0031594 | Cellular component | neuromuscular junction |
GO_0016020 | Cellular component | membrane |
GO_0043204 | Cellular component | perikaryon |
GO_0031901 | Cellular component | early endosome membrane |
GO_0030672 | Cellular component | synaptic vesicle membrane |
GO_0042734 | Cellular component | presynaptic membrane |
GO_0030425 | Cellular component | dendrite |
GO_0045202 | Cellular component | synapse |
GO_0030424 | Cellular component | axon |
GO_0033265 | Molecular function | choline binding |
GO_0015220 | Molecular function | choline transmembrane transporter activity |
GO_0005307 | Molecular function | choline:sodium symporter activity |
Gene name | SLC5A7 |
Protein name | SLC5A7 protein High affinity choline transporter 1 (hCHT1) (Hemicholinium-3-sensitive choline transporter) (CHT) (Solute carrier family 5 member 7) |
Synonyms | CHT1 |
Description | FUNCTION: High-affinity Na(+)-coupled choline transmembrane symporter . Functions as an electrogenic, voltage-dependent transporter with variable charge/choline stoichiometry . Choline uptake and choline-induced current is also Cl(-)-dependent where Cl(-) is likely a regulatory ion rather than cotransported ion . Plays a critical role in acetylcholine (ACh) synthesis by taking up the substrate choline from the synaptic cleft into the presynaptic nerve terminals after neurotransmitter release . SLC5A7/CHT1-mediated choline high-affinity transport in cholinergic neurons is the rate-limiting step for production of ACh, thereby facilitating communication by subsequent action potentials . Localized predominantly in presynaptic terminal intracellular organelles, and translocated to the plasma membrane in active form in response to neuronal activity . . |
Accessions | Q9GZV3 ENST00000264047.3 ENST00000409059.5 Q2T9H3 |